Cargando…

Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study

PURPOSE: Patients undergoing allogeneic hematopoietic cell transplantation (alloHCT) spend many weeks of treatment in an isolated environment with little room for exercise. Feasibility of a daily-performed, unassisted fascia-training program and its effects on back and foot pain, back flexibility, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Weigmann-Faßbender, Sandra, Ulbricht, Hanna, de Schultz, Marianne, Pawandenat, Christine, Kunadt, Desiree, Wolff, Michaela, Giesemann, Nadine, Prate, Katja, Schetelig, Johannes, Bornhäuser, Martin, Stölzel, Friedrich, Knauthe, Nadja, Stölzel, Friederike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758081/
https://www.ncbi.nlm.nih.gov/pubmed/36525083
http://dx.doi.org/10.1007/s00520-022-07529-x
_version_ 1784851964897525760
author Weigmann-Faßbender, Sandra
Ulbricht, Hanna
de Schultz, Marianne
Pawandenat, Christine
Kunadt, Desiree
Wolff, Michaela
Giesemann, Nadine
Prate, Katja
Schetelig, Johannes
Bornhäuser, Martin
Stölzel, Friedrich
Knauthe, Nadja
Stölzel, Friederike
author_facet Weigmann-Faßbender, Sandra
Ulbricht, Hanna
de Schultz, Marianne
Pawandenat, Christine
Kunadt, Desiree
Wolff, Michaela
Giesemann, Nadine
Prate, Katja
Schetelig, Johannes
Bornhäuser, Martin
Stölzel, Friedrich
Knauthe, Nadja
Stölzel, Friederike
author_sort Weigmann-Faßbender, Sandra
collection PubMed
description PURPOSE: Patients undergoing allogeneic hematopoietic cell transplantation (alloHCT) spend many weeks of treatment in an isolated environment with little room for exercise. Feasibility of a daily-performed, unassisted fascia-training program and its effects on back and foot pain, back flexibility, and quality of life were investigated. METHODS: Eighteen patients receiving alloHCT were randomized to an intervention (IG: n = 9; 60.7 ± 9.2 years) or control group (CG: n = 9; 54.0 ± 15.5 years) and assessed from 1 week before to 3 weeks after transplantation (t0–t3). CG received standard care physical therapy, IG performed additionally fascia training for the back and feet twice daily. Back and foot pain, back flexibility, muscle tone, and quality of life were assessed for both IG and CG at baseline and three timepoints after alloHCT. RESULTS: Fascia-training program was well accepted. No increase in hematoma formation was observed. IG reported a trend towards reduction in back pain from pre- to post-intervention (p = .074), whereas CG showed a slight increase in back pain at t3 (p = .257). IG also improved back flexibility (− 1.79 ± 5.5 cm; p = .397) while CG declined (+ 2.71 ± 5.6 cm; p = .167). No differences between groups were found for muscle tone and no significant improvements in quality of life were reported at t3. CONCLUSION: Unassisted fascia training is feasible and safe for patients undergoing alloHCT. This pilot study suggests that fascia training has the potential to improve back flexibility and reduce back pain, and might be a valuable component for physical therapy in patients receiving alloHCT.
format Online
Article
Text
id pubmed-9758081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97580812022-12-18 Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study Weigmann-Faßbender, Sandra Ulbricht, Hanna de Schultz, Marianne Pawandenat, Christine Kunadt, Desiree Wolff, Michaela Giesemann, Nadine Prate, Katja Schetelig, Johannes Bornhäuser, Martin Stölzel, Friedrich Knauthe, Nadja Stölzel, Friederike Support Care Cancer Original Article PURPOSE: Patients undergoing allogeneic hematopoietic cell transplantation (alloHCT) spend many weeks of treatment in an isolated environment with little room for exercise. Feasibility of a daily-performed, unassisted fascia-training program and its effects on back and foot pain, back flexibility, and quality of life were investigated. METHODS: Eighteen patients receiving alloHCT were randomized to an intervention (IG: n = 9; 60.7 ± 9.2 years) or control group (CG: n = 9; 54.0 ± 15.5 years) and assessed from 1 week before to 3 weeks after transplantation (t0–t3). CG received standard care physical therapy, IG performed additionally fascia training for the back and feet twice daily. Back and foot pain, back flexibility, muscle tone, and quality of life were assessed for both IG and CG at baseline and three timepoints after alloHCT. RESULTS: Fascia-training program was well accepted. No increase in hematoma formation was observed. IG reported a trend towards reduction in back pain from pre- to post-intervention (p = .074), whereas CG showed a slight increase in back pain at t3 (p = .257). IG also improved back flexibility (− 1.79 ± 5.5 cm; p = .397) while CG declined (+ 2.71 ± 5.6 cm; p = .167). No differences between groups were found for muscle tone and no significant improvements in quality of life were reported at t3. CONCLUSION: Unassisted fascia training is feasible and safe for patients undergoing alloHCT. This pilot study suggests that fascia training has the potential to improve back flexibility and reduce back pain, and might be a valuable component for physical therapy in patients receiving alloHCT. Springer Berlin Heidelberg 2022-12-16 2023 /pmc/articles/PMC9758081/ /pubmed/36525083 http://dx.doi.org/10.1007/s00520-022-07529-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Weigmann-Faßbender, Sandra
Ulbricht, Hanna
de Schultz, Marianne
Pawandenat, Christine
Kunadt, Desiree
Wolff, Michaela
Giesemann, Nadine
Prate, Katja
Schetelig, Johannes
Bornhäuser, Martin
Stölzel, Friedrich
Knauthe, Nadja
Stölzel, Friederike
Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
title Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
title_full Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
title_fullStr Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
title_full_unstemmed Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
title_short Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
title_sort fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758081/
https://www.ncbi.nlm.nih.gov/pubmed/36525083
http://dx.doi.org/10.1007/s00520-022-07529-x
work_keys_str_mv AT weigmannfaßbendersandra fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT ulbrichthanna fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT deschultzmarianne fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT pawandenatchristine fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT kunadtdesiree fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT wolffmichaela fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT giesemannnadine fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT pratekatja fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT scheteligjohannes fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT bornhausermartin fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT stolzelfriedrich fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT knauthenadja fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy
AT stolzelfriederike fasciatraininginpatientsundergoingallogeneichematopoieticcelltransplantationapilotstudy